Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lee Schwartzberg, MD, FACP
Accelerated Community Oncology Research Network
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
84 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Anniston, Alabama, United States
- Facility name not stated
Jonesboro, Arkansas, United States
- Facility name not stated
Anaheim, California, United States
- Facility name not stated
Azusa, California, United States
- Facility name not stated
Burbank, California, United States
- Facility name not stated
Campbell, California, United States
- Facility name not stated
Greenbrae, California, United States
- Facility name not stated
Hawthorne, California, United States
- Facility name not stated
Mission Hills, California, United States
- Facility name not stated
Orange, California, United States
- Facility name not stated
Oxnard, California, United States
- Facility name not stated
St. Helena, California, United States
- Facility name not stated
Fort Collins, Colorado, United States
- Facility name not stated
Norwich, Connecticut, United States
- Facility name not stated
Torrington, Connecticut, United States
- Facility name not stated
Trumbull, Connecticut, United States
- Facility name not stated
Fort Lauderdale, Florida, United States
- Facility name not stated
Lake Worth, Florida, United States
- Facility name not stated
Orange City, Florida, United States
- Facility name not stated
Pembroke Pines, Florida, United States
- Facility name not stated
St. Petersburg, Florida, United States
- Facility name not stated
Titusville, Florida, United States
- Facility name not stated
Weston, Florida, United States
- Facility name not stated
Augusta, Georgia, United States
- Facility name not stated
Columbus, Georgia, United States
- Facility name not stated
Lawrenceville, Georgia, United States
- Facility name not stated
Marietta, Georgia, United States
- Facility name not stated
Valdosta, Georgia, United States
- Facility name not stated
Elmhurst, Illinois, United States
- Facility name not stated
Harvey, Illinois, United States
- Facility name not stated
Joliet, Illinois, United States
- Facility name not stated
Quincy, Illinois, United States
- Facility name not stated
Skokie, Illinois, United States
- Facility name not stated
South Bend, Indiana, United States
- Family Medicine of Vincennes
Vincennes, Indiana, United States
- Facility name not stated
Arnes, Iowa, United States
- Facility name not stated
Bettendorf, Iowa, United States
- Facility name not stated
Mason City, Iowa, United States
- Facility name not stated
Waterloo, Iowa, United States
- Facility name not stated
Hazard, Kentucky, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2008
- Primary completion
- 31 Jul 2012
- Completion
- 31 Aug 2012
- Last update posted
- 6 Nov 2013
- Registered enrollment
- 601
- Registry id
- NCT00828841
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.